Moderna to provide business and pipeline updates at the 2022 j.p. morgan healthcare conference

Cambridge, ma / accesswire / january 3, 2022 / moderna, inc. (nasdaq:mrna), a biotechnology company pioneering messenger rna (mrna) therapeutics and vaccines, today announced that ceo stÉphane bancel will present an update on the company and its pipeline of mrna development programs at the virtual 40th annual j.p. morgan healthcare conference on monday, january 10th at 8:15 a.m.
MRNA Ratings Summary
MRNA Quant Ranking